Welcome to our dedicated page for Vext Science news (Ticker: VEXTF), a resource for investors and traders seeking the latest updates and insights on Vext Science stock.
Vext Science, Inc. (OTCQX: VEXTF) generates frequent news as a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Company news releases highlight developments across its cultivation, manufacturing and retail dispensary activities, as well as updates on its Vapen™ branded products and Herbal Wellness Center dispensaries.
On this page, readers can follow Vext’s announcements about financial results, including quarterly earnings releases that discuss revenue, EBITDA, Adjusted EBITDA and Cash Flow Margin, along with explanations of these non-IFRS financial measures. The company also issues notices about upcoming earnings calls and webcasts, providing details for investors who want to listen to management’s commentary.
Vext’s news flow often covers operational milestones in Ohio, such as regulatory approvals from the Ohio Division of Cannabis Control, the opening of new Herbal Wellness Center dispensaries, and progress on additional dual-use dispensary licenses under the 10(B) program. Updates describe the status of its Tier 1 cultivation facility, manufacturing facility and multiple dispensary locations in cities including Jackson, Columbus, Athens, Jeffersonville, Portsmouth and Fairfield.
Other news items may include corporate and capital markets disclosures, such as early warning reports by significant securityholders, changes in auditors, and voting results from annual general meetings. Together, these updates provide a detailed view of how Vext is operating its vertically integrated cannabis platform in its core states of Arizona and Ohio. Investors and followers of the cannabis sector can use this news feed to review VEXTF-related announcements and company statements in one place.
Vext Science (OTCQX:VEXTF) has secured a provisional license for its sixth Ohio dispensary in Fairfield, marking continued expansion in the state. The 3,825 square foot facility, expected to be operational in Q4 2025, will be strategically located next to Jungle Jim's International Market, benefiting from high consumer traffic.
The company will invest approximately $1 million in the build-out, funded through operating cash flow. The location features a drive-thru format and holds exclusive rights as the only permitted dispensary in Fairfield. This expansion advances Vext's progress toward Ohio's dispensary license cap of eight locations, complementing its existing vertically integrated operations including a Tier 1 cultivation facility and manufacturing operations.
Vext Science (OTCQX: VEXTF), a U.S.-based cannabis operator with operations in Arizona and Ohio, has scheduled the release of its Q1 2025 financial results for May 21, 2025, before market open. The company will host a conference call and webcast on the same day at 8:00 AM ET to discuss the results.
Interested participants can join via phone using the dial-in numbers +1-647-849-3159 or 1-833-752-3966 (Conference ID: 10199977). A replay will be available until June 4, 2025, using playback number 5885585. The webcast can be accessed at www.gowebcasting.com/14070, and a replay will be available on Vext's investor website after the call.
Vext Science (VEXTF) has announced the strategic sale of its Kentucky medical cannabis processing license for US$880,000 through its subsidiary Vapen Kentucky. The transaction aligns with the company's focused approach on its core markets in Arizona and Ohio.
Prior to the sale, on March 16, 2025, Vext acquired the remaining 50% membership interest in Vapen Kentucky from its joint venture partner using non-cash consideration. Following the transaction's closure, Vapen Kentucky will redirect its focus to hemp-related business opportunities.
The proceeds will be allocated towards:
- Repayment of existing credit facilities
- Development of Ohio retail footprint
- General corporate purposes
Vext Science (VEXTF) has completed the acquisition of two cannabis dispensaries from Big Perm's Dispensary Ohio for US$8.1 million, doubling its retail presence in Ohio. The acquisition adds locations in Athens and Jeffersonville to existing dispensaries in Jackson and Columbus.
The company is now fully vertically integrated in Ohio with:
- A Tier I cultivation facility (25,000 sq ft, expandable to 50,000 sq ft)
- A manufacturing facility
- Four operational medical and adult-use dispensaries
Vext has secured approval to develop three additional dual-use dispensaries and expects its Portsmouth location to commence operations in Q2/Q3 2025. The company is on track to reach Ohio's state license cap of eight dispensaries by early 2026, with cash flow projected to return to growth in Q4 2024.
Vext Science (VEXTF) reported strong Q4 2024 financial results, marking its strongest operating quarter in recent years. Revenue reached $10.2 million in Q4 2024, up 13% quarter-over-quarter, driven by Ohio adult-use sales and Arizona operations. Adjusted EBITDA grew significantly to $3.2 million (compared to $0.5 million in Q4 2023), while cash flow from operations turned positive at $4 million.
The company received approval from Ohio's Division of Cannabis Control to acquire Big Perm dispensaries in Athens and Jeffersonville. This expansion will double Vext's Ohio retail footprint to four locations. Additionally, Vext secured a provisional license for a fifth dispensary in Portsmouth, Ohio, expected to open in Q2/Q3 2025. The company aims to reach Ohio's dispensary license cap of eight locations by early 2026.
In Arizona, despite a 25% decline in statewide per-store sales, Vext maintained market share through effective retail traffic management and improved yields at its Eloy cultivation facility.
Vext Science (CSE: VEXT, OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, has scheduled its Q4 and fiscal 2024 financial results announcement for March 31, 2025, before market open.
The company will host a conference call and webcast on the same day at 8:00 AM ET to discuss the quarterly and full-year 2024 results. Participants can join via phone using dial-in numbers +1-647-849-3159 or 1-833-752-3966 (Conference ID: 10197749). A replay will be available until April 14, 2025, using playback number 5786741.
Vext Science (VEXTF) has relocated and expanded its Herbal Wellness Center dispensary in Jackson, Ohio, doubling its retail footprint. The new location features an 8,350 square foot space, including 4,500 square feet for retail operations and a drive-thru window for improved customer convenience.
The company operates a vertically integrated business in Ohio, including a Tier I cultivation facility, a manufacturing facility, and two operational dispensaries in Jackson and Columbus. Vext is pursuing expansion to reach Ohio's maximum limit of eight dispensaries, with plans to add locations in Athens, Jeffersonville, and Portsmouth through its Ohio Expansion Transaction, expected to close in Q1 2025.
The company has received approval to develop three additional dual-use dispensaries under the DCC's 10(B) license program. The new Jackson location is leased with a purchase option, offering flexibility for future growth and potential sublease opportunities to offset occupancy costs.